The Bacterial Connection
It turns out that there may be a very direct relationship between asthma and the presence of bacteria in the lungs. As a result, a new treatment protocol for asthma may be on the horizon.
The $7.5 million asthma study being conducted by National Jewish Medical and Research Center—one of the country's premiere centers for respiratory medicine—will enroll 126 asthma patients from around the U.S. to examine the relationship between asthma and bacteria, and its response to treatment with antibacterial agents.
Remarkable Case Study
The study was inspired by a severely debilitated asthma patient who was treated with antibacterial agents when a lung biopsy revealed the presence of bacteria.
Her health underwent such a dramatic reversal that she has since run a sprint-distance triathlon and a 10K race.
Implications for Natural Treatment
This groundbreaking research might explain why asthma sufferers who use MesoSilver® colloidal silver, which is a natural antibacterial agent, report such excellent results and dramatic improvement in their asthma symptoms.
Not all asthma patients show the presence of bacteria, and not everyone with the bacteria has asthma, but there is a hypothesis that it may be an interaction between allergens and the bacteria—along with a possible genetic predisposition and a certain sequence of exposure—that triggers asthma.
Key Research Findings
- Direct correlation identified between lung bacteria and asthma symptoms
- Antibacterial treatment shows dramatic improvement in select patients
- Potential interaction between allergens, bacteria, and genetic factors
- Early bacterial treatment may prevent asthma development
- New non-invasive diagnostic methods under investigation
Prevention Possibilities
There is even a chance that treating bacterial infections immediately when they occur could prevent asthma altogether. This represents a paradigm shift in our understanding of asthma etiology and opens new avenues for both prevention and treatment.
Advancing Diagnostic Methods
The study is also investigating a new method of identifying lung bacteria to replace the highly uncomfortable bronchoscopy, which requires patient sedation. This advancement could make diagnosis more accessible and comfortable for patients.
Learn More About Natural Antibacterial Support
Discover how MesoSilver® colloidal silver may support respiratory health
Important Notice: These statements have not been evaluated by the Food and Drug Administration. MesoSilver is not intended to diagnose, treat, cure, or prevent any disease. The information presented here is for educational purposes and is based on independent research. Consult with a qualified healthcare provider before starting any new health protocol.